Growth Hormone Releasing Peptides (GHRPs) stimulate GH release via the ghrelin receptor — a complementary pathway to GHRH analogues. This hub covers Ipamorelin, GHRP-2, and GHRP-6: mechanisms, selectivity profiles, stacking protocols, and which compound fits each research goal.
Growth Hormone Releasing Peptides (GHRPs) are a class of synthetic peptides that stimulate pituitary GH secretion by binding to the GHS-R1a receptor — the same receptor activated by the endogenous hormone ghrelin. Unlike GHRH analogues (Sermorelin, CJC-1295, Tesamorelin), which mimic the hypothalamic GHRH signal, GHRPs work through a distinct and complementary receptor pathway.
This mechanistic distinction is clinically important: when a GHRH analogue and a GHRP are administered together, they act on different receptors simultaneously, producing synergistic GH release 2–10× greater than either peptide alone. This is why CJC-1295 + Ipamorelin is one of the most studied peptide combinations in GH secretagogue research.
The three primary GHRPs in research use — Ipamorelin, GHRP-2, and GHRP-6 — differ significantly in their selectivity profiles. Ipamorelin is the most selective, stimulating GH release with minimal cortisol, prolactin, or appetite co-stimulation. GHRP-2 produces the highest GH amplitude. GHRP-6 causes the most pronounced appetite stimulation.
Selective GH pulse, lean mass, sleep quality
Maximum GH release, muscle growth, body composition
GH release, appetite stimulation, muscle mass
| Parameter | Ipamorelin | GHRP-2 | GHRP-6 |
|---|---|---|---|
| Receptor | GHS-R1a (selective) | GHS-R1a + CD36 | GHS-R1a + ghrelin R |
| Half-Life | ~2 hours | ~30 min | ~15–60 min |
| GH Amplitude | Moderate | High ★★★ | High ★★★ |
| Cortisol Stimulation | Minimal ✓ | Moderate ⚠ | Moderate–High ⚠ |
| Prolactin Stimulation | Minimal ✓ | Moderate ⚠ | Moderate ⚠ |
| Appetite Stimulation | Minimal ✓ | Moderate | High (significant) |
| Water Retention | Mild | Mild–Moderate | Mild–Moderate |
| Best For | Recomp, anti-aging, sleep | Max muscle, body comp | Bulking, hard gainers |
| Typical Dose | 200–300 mcg | 100–200 mcg | 100–200 mcg |
| Dosing Frequency | 2–3× daily | 2–3× daily | 2–3× daily |
| FDA Status | Not approved | Not approved | Not approved |
| Research Volume | Moderate | High | High |
Why stacking works: GHRH analogues prime the pituitary by increasing GHRH receptor expression and sensitivity, while GHRPs simultaneously trigger GH release via the ghrelin receptor. The two signals converge on the same somatotroph cells but through different intracellular pathways, producing additive-to-synergistic GH pulses.
GHRP (Growth Hormone Releasing Peptide) is a class of synthetic peptides that stimulate GH release by binding to the GHS-R1a (ghrelin) receptor in the pituitary gland and hypothalamus. Unlike GHRH analogues (Sermorelin, CJC-1295, Tesamorelin) which mimic the natural GHRH signal, GHRPs mimic ghrelin and work through a complementary receptor pathway. The two families are synergistic — combining a GHRH analogue with a GHRP produces 2–10x greater GH release than either alone.
All three bind the GHS-R1a receptor but with different selectivity profiles. Ipamorelin is the most selective — it stimulates GH release without significantly affecting cortisol, prolactin, or appetite. GHRP-2 produces the highest GH amplitude but causes moderate cortisol and prolactin stimulation. GHRP-6 produces strong GH release and significant appetite stimulation (useful for bulking), but also causes the most cortisol and prolactin co-stimulation of the three.
Ipamorelin is generally preferred for fat loss protocols because it stimulates GH release without the cortisol increase associated with GHRP-2 and GHRP-6. Elevated cortisol promotes fat storage and muscle catabolism, counteracting the fat-loss benefits of GH. For maximum fat loss, Ipamorelin is typically stacked with CJC-1295 (no DAC) or Tesamorelin.
GHRP-2 is preferred for maximum muscle building due to its higher GH amplitude. GHRP-6 is an alternative for hard gainers who benefit from appetite stimulation. Both are typically stacked with a GHRH analogue (CJC-1295 or Sermorelin) for synergistic GH release. Ipamorelin is a good middle-ground option when cortisol management is important.
Yes — GHRH + GHRP stacking is one of the most well-studied peptide combination strategies. GHRH analogues (Sermorelin, CJC-1295, Tesamorelin) prime the pituitary by increasing GHRH receptor sensitivity, while GHRPs (Ipamorelin, GHRP-2, GHRP-6) trigger GH release via the ghrelin receptor. The combination produces synergistic GH pulses 2–10x greater than either peptide alone.
Common side effects across all GHRPs include water retention, increased hunger (most pronounced with GHRP-6), injection site reactions, and transient flushing or headache. GHRP-2 and GHRP-6 also cause moderate cortisol and prolactin stimulation, which can promote fat storage and suppress testosterone at high doses. Ipamorelin has the most favorable side effect profile of the three.
Third-party tested for purity and potency. HPLC-verified. COA available for every batch.
Shop GHRP PeptidesMedical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.